Patricia Drake
Corporate Officer/Principal chez TREVENA, INC.
Fortune : 41 760 $ au 31/05/2024
Postes actifs de Patricia Drake
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TREVENA, INC. | Corporate Officer/Principal | 11/11/2021 | - |
Historique de carrière de Patricia Drake
Anciens postes connus de Patricia Drake
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2021 | 01/09/2021 |
| MSD Finland Oy | Directeur Général | 01/01/2019 | 01/05/2021 |
Formation de Patricia Drake
| Wichita State University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| Finlande | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TREVENA, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
| MSD Finland Oy |
- Bourse
- Insiders
- Patricia Drake
- Expérience
